| __timestamp | Amphastar Pharmaceuticals, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 1488000000 |
| Thursday, January 1, 2015 | 37065000 | 1525000000 |
| Friday, January 1, 2016 | 41199000 | 2111000000 |
| Sunday, January 1, 2017 | 43415000 | 1848000000 |
| Monday, January 1, 2018 | 57564000 | 1213000000 |
| Tuesday, January 1, 2019 | 68853000 | 1010000000 |
| Wednesday, January 1, 2020 | 67229000 | 997000000 |
| Friday, January 1, 2021 | 60932000 | 967000000 |
| Saturday, January 1, 2022 | 74771000 | 838000000 |
| Sunday, January 1, 2023 | 73741000 | 953000000 |
| Monday, January 1, 2024 | 998000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical industry, research and development (R&D) is the lifeblood of innovation. Over the past decade, Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Teva's R&D expenses have seen a significant decline, dropping by approximately 36%, from a peak in 2016. This shift reflects Teva's strategic realignment amidst industry challenges. In contrast, Amphastar has steadily increased its R&D spending by over 160% during the same period, underscoring its commitment to growth and innovation. This divergence highlights the varied strategies companies adopt to navigate the competitive landscape. As the pharmaceutical sector continues to face unprecedented challenges, understanding these investment trends offers valuable insights into the future of drug development and market dynamics.
Sanofi vs Teva Pharmaceutical Industries Limited: Strategic Focus on R&D Spending
Teva Pharmaceutical Industries Limited or Intra-Cellular Therapies, Inc.: Who Invests More in Innovation?
Teva Pharmaceutical Industries Limited or Bio-Techne Corporation: Who Invests More in Innovation?
R&D Spending Showdown: Teva Pharmaceutical Industries Limited vs PTC Therapeutics, Inc.
Comparing Innovation Spending: Bio-Techne Corporation and Amphastar Pharmaceuticals, Inc.
Comparing Innovation Spending: Ascendis Pharma A/S and Amphastar Pharmaceuticals, Inc.
R&D Insights: How Grifols, S.A. and Amphastar Pharmaceuticals, Inc. Allocate Funds
Corcept Therapeutics Incorporated or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
MorphoSys AG or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Vericel Corporation vs Amphastar Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Protagonist Therapeutics, Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Ligand Pharmaceuticals Incorporated and Amphastar Pharmaceuticals, Inc.